Table 1.
Cytokines, Adipokines and Hormones | Primary Source | Functions | Changes in Blood Levels in COPD Patients | References |
---|---|---|---|---|
Adiponectin | Adipocytes | Insulin sensitizer, suppress inflammation | ↑ compared to healthy smokers and nonsmkers; correlated with the residual volume, blood TNF-α levels and mortality; inversely correlated with the predicted %FEV1; ↑ during acute exacerbations | [30,31,32,33,34] |
Leptin | Adipocytes, bronchial epithelial cells, alveolar type II pneumocytes, lung macrophages | Appetite control, promote inflammation; regulate hematopoiesis, angiogenesis, wound healing | ↓ in COPD patients with low BMI compared to COPD patients with normal and high BMI and healthy control; ↑ and correlated with TNF-α during acute exacerbation; not correlated with TNF-α in stable COPD patients; plasma and sputum leptin levels are inversely correlated | [23,24,25,29] |
Resistin | Peripheral blood mononuclear cells, adipocytes | Promote insulin resistance and inflammation through IL-6 and TNF-α production | Inversely correlated with FEV1% predicted | [35] |
TNF-α | Stromal vascular fraction cells, adipocytes, monocytes | Promote inflammation; antagonize insulin signaling | ↑ compared to healthy control; ↑ production from the peripheral blood monocytes in lean COPD patients | [13,14,15] |
IL-6 | Adipocytes, atromal vascular fraction cells, liver, muscle | Promote inflammation; appetite loss | ↑ compared to healthy control | [14] |
Ghrelin | X/A-like cells | Stimulate appetite and GH release | ↑ in underweight patients compared with normal weight patients and healthy control subjects; positively correlated with residual lung volume; inversely correlated with FEV1% predicted | [36] |
Abbreviations: ↑, increase; ↓, decrease.